HOPO Therapeutics
PrivateLast Round
Grant
Oct 28, 2024
Total Funding Raised
$227.88M
Company Overview
HOPO Therapeutics operates in Healthcare & Life Sciences and is based in Emeryville, California. Its latest recorded funding round was a Grant round in October 2024.
HOPO Therapeutics is a biotechnology company developing orally-available chelating agents for the treatment and prevention of heavy metal poisoning and radiological contamination.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Defense Tech
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HOPO Therapeutics Comparables
Compare HOPO Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Captura Biopharma | 93% | |
| EmeraMed Limited | 78% | |
| Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG | 75% |
For institutional investors. Book with your work email.
HOPO Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 28, 2024 | ||||
| Grant | Nov 2, 2023 | ||||
| Grant | Jun 8, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
HOPO Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cyclotron Road | Grant |
| Creative Destruction Lab | Accelerator |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Activate | Grant |
| US Department of Energy (ARPA-E) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors grew 33% MoM, reaching 1.6K.
- Apr 6, 2025
Grew 70% QoQ from 10 to 17 employees.
For institutional investors. Book with your work email.
HOPO Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HOPO Therapeutics's valuation, stock price, and market status.
Is HOPO Therapeutics a public or private company?
HOPO Therapeutics is a private company.
What is the current stock price of HOPO Therapeutics?
HOPO Therapeutics is a private company, so its shares have no public market price. Caplight tracks HOPO Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HOPO Therapeutics worth (valuation)?
Valuation information for HOPO Therapeutics is not publicly available.
Can I buy HOPO Therapeutics stock?
HOPO Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HOPO Therapeutics's last funding round?
HOPO Therapeutics's most recent funding round was Grant on October 28, 2024.
Who are the main investors in HOPO Therapeutics?
Key investors in HOPO Therapeutics include Cyclotron Road, Creative Destruction Lab, Public Health Emergency Medical Countermeasures Enterprise, Activate, US Department of Energy (ARPA-E).
Will HOPO Therapeutics IPO soon?
No public IPO plans have been announced for HOPO Therapeutics.
How can I track HOPO Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in HOPO Therapeutics's shares on secondary markets.